Evaluation status available after sign-in
About the journal
npj Precision Oncology is an open-access journal published by Nature Portfolio in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 3,490 EUR. Declared review time at DOAJ: 18 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Nature Portfolio
- ISSN
- 2397-768X
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,490 EUR
- Articles in DOAJ
- 1415
- Declared review time
- 18 weeks
- Declared peer-review model
- other
- Official website
- https://www.nature.com/npjprecisiononcology/
Index listings
- DOAJ · 2017-10-09
- PUBMED · 2020-11-13
- Indexing
- DOAJ · PUBMED
- APC
- 3,490 EUR
- Declared review time (DOAJ)
- 18 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
1415
Most recent article
last month
Average review time (journal-declared via DOAJ)
18weeks
Works in OpenAlex
1537
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
78
i10-index
656
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2017-10-09
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 87%
- ORCID iDs in current deposits
- 35%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Nature Partner Journals precision oncologyPrecision oncology
- Source type
- journal
- NLM unique ID (PubMed)
- 101708166
Classification2
Subjects (DOAJ)
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
LCC codes
RC254-282
Subject areas
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Radiomics and Machine Learning in Medical Imaging
- Lung Cancer Treatments and Mutations
Show all subjects (75)
- Radiomics and Machine Learning in Medical Imaging
- AI in cancer detection
- Radiomics and Machine Learning in Medical Imaging
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Breast Cancer Treatment Studies
- Glioma Diagnosis and Treatment
- Single-cell and spatial transcriptomics
- AI in cancer detection
- Cancer Cells and Metastasis
- Single-cell and spatial transcriptomics
- AI in cancer detection
- Cancer Cells and Metastasis
- BRCA gene mutations in cancer
- Cancer Cells and Metastasis
- Genetic factors in colorectal cancer
- Immune cells in cancer
- RNA modifications and cancer
- RNA modifications and cancer
- Genetic factors in colorectal cancer
- Glioma Diagnosis and Treatment
- Single-cell and spatial transcriptomics
- Glioma Diagnosis and Treatment
- Immune cells in cancer
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Chromatin Remodeling and Cancer
- Colorectal Cancer Treatments and Studies
- Ovarian cancer diagnosis and treatment
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
- Immunotherapy and Immune Responses
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
- Artificial Intelligence in Healthcare and Education
- Immunotherapy and Immune Responses
- Colorectal Cancer Treatments and Studies
- Genetic factors in colorectal cancer
- Colorectal Cancer Treatments and Studies
- Head and Neck Cancer Studies
- Immunotherapy and Immune Responses
- Ferroptosis and cancer prognosis
- HER2/EGFR in Cancer Research
- Cancer, Hypoxia, and Metabolism
- CAR-T cell therapy research
- PARP inhibition in cancer therapy
- Sarcoma Diagnosis and Treatment
- PARP inhibition in cancer therapy
- PARP inhibition in cancer therapy
- Cancer, Hypoxia, and Metabolism
- CAR-T cell therapy research
- Cancer, Hypoxia, and Metabolism
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Epigenetics and DNA Methylation
- Lung Cancer Diagnosis and Treatment
- Melanoma and MAPK Pathways
- Lung Cancer Diagnosis and Treatment
- Cell Image Analysis Techniques
- Protein Degradation and Inhibitors
- Ovarian cancer diagnosis and treatment
Keywords (DOAJ)
- carcinogenesis
- targeted immunotherapy
- panomics
- oncology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ